| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Aneurysm, Thoracic | 12 | 2025 | 98 | 2.360 |
Why?
|
| Early Detection of Cancer | 8 | 2022 | 484 | 2.080 |
Why?
|
| Blood Vessel Prosthesis Implantation | 12 | 2024 | 239 | 1.970 |
Why?
|
| Colorectal Neoplasms | 8 | 2022 | 1069 | 1.960 |
Why?
|
| Thoracic Surgery | 7 | 2024 | 62 | 1.740 |
Why?
|
| Emigrants and Immigrants | 6 | 2018 | 47 | 1.590 |
Why?
|
| Transcatheter Aortic Valve Replacement | 7 | 2021 | 74 | 1.440 |
Why?
|
| Endovascular Procedures | 11 | 2021 | 334 | 1.420 |
Why?
|
| Cardiac Surgical Procedures | 7 | 2024 | 519 | 1.290 |
Why?
|
| Aortic Valve | 10 | 2023 | 277 | 1.200 |
Why?
|
| Aortic Aneurysm | 5 | 2020 | 82 | 1.080 |
Why?
|
| Societies, Medical | 5 | 2024 | 645 | 1.080 |
Why?
|
| Patient Navigation | 3 | 2018 | 16 | 1.060 |
Why?
|
| Heart Valve Prosthesis Implantation | 5 | 2021 | 199 | 1.030 |
Why?
|
| Colonoscopy | 3 | 2022 | 304 | 0.920 |
Why?
|
| Aortic Valve Stenosis | 3 | 2021 | 169 | 0.900 |
Why?
|
| Surgeons | 3 | 2023 | 298 | 0.730 |
Why?
|
| Heart Valve Prosthesis | 5 | 2021 | 107 | 0.640 |
Why?
|
| Hepatitis B, Chronic | 2 | 2018 | 34 | 0.620 |
Why?
|
| Postoperative Complications | 7 | 2024 | 2603 | 0.610 |
Why?
|
| Computed Tomography Angiography | 4 | 2022 | 166 | 0.600 |
Why?
|
| Aortography | 2 | 2018 | 67 | 0.590 |
Why?
|
| Humans | 66 | 2025 | 95992 | 0.580 |
Why?
|
| Middle Aged | 32 | 2025 | 28299 | 0.570 |
Why?
|
| Communication Barriers | 1 | 2018 | 32 | 0.550 |
Why?
|
| Aorta, Thoracic | 4 | 2024 | 170 | 0.540 |
Why?
|
| Chicago | 7 | 2020 | 1505 | 0.540 |
Why?
|
| Intention | 1 | 2018 | 52 | 0.540 |
Why?
|
| Aged | 24 | 2025 | 20927 | 0.530 |
Why?
|
| Health Education | 1 | 2018 | 107 | 0.520 |
Why?
|
| Retrospective Studies | 24 | 2025 | 10307 | 0.520 |
Why?
|
| Software | 1 | 2021 | 698 | 0.500 |
Why?
|
| Public Health Surveillance | 1 | 2016 | 25 | 0.490 |
Why?
|
| Female | 40 | 2025 | 49980 | 0.490 |
Why?
|
| Male | 41 | 2025 | 45792 | 0.480 |
Why?
|
| Bioprosthesis | 3 | 2021 | 43 | 0.480 |
Why?
|
| Education, Public Health Professional | 1 | 2015 | 2 | 0.460 |
Why?
|
| Women's Health | 1 | 2016 | 109 | 0.450 |
Why?
|
| Urban Health | 1 | 2015 | 55 | 0.450 |
Why?
|
| Community-Based Participatory Research | 1 | 2015 | 38 | 0.450 |
Why?
|
| Gastrointestinal Diseases | 1 | 2016 | 153 | 0.440 |
Why?
|
| Acute Disease | 9 | 2025 | 859 | 0.430 |
Why?
|
| Colonic Polyps | 1 | 2015 | 137 | 0.420 |
Why?
|
| Risk Assessment | 7 | 2024 | 2498 | 0.410 |
Why?
|
| Mass Screening | 4 | 2020 | 710 | 0.400 |
Why?
|
| Treatment Outcome | 18 | 2024 | 9228 | 0.400 |
Why?
|
| Michigan | 7 | 2021 | 57 | 0.370 |
Why?
|
| Health Status Disparities | 1 | 2015 | 221 | 0.370 |
Why?
|
| Primary Health Care | 1 | 2016 | 391 | 0.370 |
Why?
|
| Aorta | 4 | 2022 | 294 | 0.370 |
Why?
|
| Education, Medical | 1 | 2015 | 252 | 0.360 |
Why?
|
| Stents | 4 | 2021 | 422 | 0.330 |
Why?
|
| Endocarditis, Bacterial | 2 | 2020 | 39 | 0.320 |
Why?
|
| United States | 11 | 2024 | 7785 | 0.320 |
Why?
|
| Blood Vessel Prosthesis | 3 | 2021 | 248 | 0.310 |
Why?
|
| Hospital Mortality | 7 | 2020 | 485 | 0.310 |
Why?
|
| Minority Groups | 3 | 2020 | 154 | 0.310 |
Why?
|
| Heart Defects, Congenital | 2 | 2024 | 383 | 0.310 |
Why?
|
| Pain, Postoperative | 3 | 2021 | 277 | 0.310 |
Why?
|
| Time Factors | 9 | 2021 | 5593 | 0.280 |
Why?
|
| Adult | 14 | 2023 | 28636 | 0.280 |
Why?
|
| Mesenteric Ischemia | 2 | 2018 | 9 | 0.270 |
Why?
|
| Acute Kidney Injury | 2 | 2024 | 341 | 0.260 |
Why?
|
| Religion and Psychology | 1 | 2006 | 18 | 0.250 |
Why?
|
| Morbidity | 2 | 2024 | 162 | 0.250 |
Why?
|
| Community-Institutional Relations | 1 | 2006 | 31 | 0.250 |
Why?
|
| Aortic Diseases | 2 | 2024 | 104 | 0.250 |
Why?
|
| Analgesics, Opioid | 2 | 2021 | 514 | 0.240 |
Why?
|
| Follow-Up Studies | 5 | 2020 | 3922 | 0.240 |
Why?
|
| Behavior Therapy | 1 | 2006 | 95 | 0.240 |
Why?
|
| Spirituality | 1 | 2006 | 88 | 0.240 |
Why?
|
| China | 3 | 2020 | 264 | 0.230 |
Why?
|
| Ischemia | 2 | 2018 | 256 | 0.230 |
Why?
|
| Rural Population | 1 | 2006 | 171 | 0.230 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2006 | 45 | 0.230 |
Why?
|
| Practice Guidelines as Topic | 2 | 2024 | 1096 | 0.230 |
Why?
|
| Risk Factors | 10 | 2024 | 5992 | 0.230 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2006 | 50 | 0.230 |
Why?
|
| Religion and Medicine | 1 | 2006 | 122 | 0.230 |
Why?
|
| Chronic Disease | 4 | 2024 | 983 | 0.230 |
Why?
|
| Weight Loss | 1 | 2006 | 240 | 0.220 |
Why?
|
| Insurance Coverage | 2 | 2015 | 144 | 0.210 |
Why?
|
| Databases, Factual | 3 | 2023 | 1014 | 0.210 |
Why?
|
| Healthcare Disparities | 4 | 2016 | 492 | 0.200 |
Why?
|
| Evidence-Based Medicine | 3 | 2020 | 458 | 0.190 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2015 | 570 | 0.190 |
Why?
|
| Curriculum | 3 | 2015 | 616 | 0.190 |
Why?
|
| Genetic Testing | 1 | 2006 | 566 | 0.180 |
Why?
|
| Text Messaging | 1 | 2022 | 35 | 0.180 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2021 | 32 | 0.170 |
Why?
|
| Diverticulum | 1 | 2021 | 45 | 0.170 |
Why?
|
| Telecommunications | 1 | 2020 | 8 | 0.170 |
Why?
|
| Long Term Adverse Effects | 1 | 2020 | 6 | 0.160 |
Why?
|
| Risk | 2 | 2020 | 666 | 0.160 |
Why?
|
| Heart Valve Diseases | 1 | 2021 | 122 | 0.160 |
Why?
|
| Hepatitis B Surface Antigens | 2 | 2018 | 25 | 0.160 |
Why?
|
| Reoperation | 5 | 2022 | 712 | 0.160 |
Why?
|
| Intercostal Nerves | 1 | 2020 | 4 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 207 | 0.160 |
Why?
|
| Endocarditis | 1 | 2020 | 25 | 0.160 |
Why?
|
| Deglutition Disorders | 1 | 2021 | 126 | 0.160 |
Why?
|
| Denervation | 1 | 2020 | 25 | 0.160 |
Why?
|
| Congresses as Topic | 1 | 2020 | 125 | 0.160 |
Why?
|
| Aged, 80 and over | 6 | 2021 | 7224 | 0.160 |
Why?
|
| Obesity | 1 | 2006 | 1029 | 0.150 |
Why?
|
| Abscess | 1 | 2020 | 94 | 0.150 |
Why?
|
| Neoplasms | 1 | 2015 | 3242 | 0.150 |
Why?
|
| Cerebrovascular Disorders | 1 | 2020 | 146 | 0.150 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 94 | 0.150 |
Why?
|
| Panax | 2 | 2011 | 171 | 0.150 |
Why?
|
| Marketing of Health Services | 1 | 2019 | 15 | 0.150 |
Why?
|
| Prosthesis-Related Infections | 1 | 2020 | 62 | 0.150 |
Why?
|
| Patient Admission | 1 | 2020 | 122 | 0.150 |
Why?
|
| Narcotics | 1 | 2020 | 72 | 0.150 |
Why?
|
| Cryosurgery | 1 | 2020 | 68 | 0.150 |
Why?
|
| Prosthesis Failure | 1 | 2020 | 127 | 0.150 |
Why?
|
| Disease Outbreaks | 1 | 2020 | 157 | 0.150 |
Why?
|
| Splanchnic Circulation | 1 | 2018 | 14 | 0.150 |
Why?
|
| Hospitals, High-Volume | 1 | 2019 | 43 | 0.150 |
Why?
|
| Cerebrovascular Circulation | 1 | 2020 | 243 | 0.150 |
Why?
|
| Informed Consent | 1 | 2021 | 281 | 0.150 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2020 | 121 | 0.140 |
Why?
|
| Device Removal | 1 | 2020 | 169 | 0.140 |
Why?
|
| Endothelial Cells | 1 | 2021 | 477 | 0.140 |
Why?
|
| Aortic Rupture | 1 | 2018 | 58 | 0.140 |
Why?
|
| Hospitals, University | 1 | 2018 | 199 | 0.140 |
Why?
|
| Occult Blood | 1 | 2018 | 28 | 0.140 |
Why?
|
| Consensus | 1 | 2020 | 372 | 0.130 |
Why?
|
| Models, Statistical | 1 | 2021 | 594 | 0.130 |
Why?
|
| Pain Management | 1 | 2020 | 180 | 0.130 |
Why?
|
| Vascular Calcification | 1 | 2018 | 54 | 0.130 |
Why?
|
| Forecasting | 1 | 2018 | 317 | 0.130 |
Why?
|
| Quantitative Trait Loci | 1 | 2021 | 632 | 0.130 |
Why?
|
| Health Expenditures | 1 | 2018 | 101 | 0.130 |
Why?
|
| Community Health Services | 1 | 2018 | 81 | 0.130 |
Why?
|
| Viscera | 1 | 2016 | 19 | 0.130 |
Why?
|
| Hospitals | 1 | 2019 | 329 | 0.120 |
Why?
|
| Seroepidemiologic Studies | 1 | 2016 | 57 | 0.120 |
Why?
|
| Influenza, Human | 1 | 2020 | 370 | 0.120 |
Why?
|
| Prognosis | 3 | 2020 | 3993 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 935 | 0.120 |
Why?
|
| Patient Participation | 1 | 2018 | 241 | 0.120 |
Why?
|
| Registries | 1 | 2021 | 998 | 0.120 |
Why?
|
| Kidney Failure, Chronic | 1 | 2020 | 432 | 0.120 |
Why?
|
| Directive Counseling | 1 | 2016 | 35 | 0.120 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 500 | 0.120 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 2885 | 0.120 |
Why?
|
| Risk Reduction Behavior | 1 | 2016 | 99 | 0.120 |
Why?
|
| Polyps | 1 | 2015 | 26 | 0.110 |
Why?
|
| Vietnam | 1 | 2015 | 15 | 0.110 |
Why?
|
| Cambodia | 1 | 2015 | 6 | 0.110 |
Why?
|
| Thrombosis | 1 | 2018 | 326 | 0.110 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2015 | 66 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2018 | 387 | 0.110 |
Why?
|
| Cultural Diversity | 2 | 2013 | 68 | 0.110 |
Why?
|
| Schools, Medical | 2 | 2013 | 144 | 0.110 |
Why?
|
| Logistic Models | 1 | 2018 | 1273 | 0.110 |
Why?
|
| Communication | 1 | 2018 | 478 | 0.110 |
Why?
|
| Universities | 1 | 2015 | 154 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 1819 | 0.100 |
Why?
|
| Syndrome | 2 | 2024 | 450 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 1230 | 0.100 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 640 | 0.090 |
Why?
|
| Personnel Selection | 1 | 2013 | 64 | 0.090 |
Why?
|
| Sexual and Gender Minorities | 1 | 2016 | 250 | 0.090 |
Why?
|
| Survival Rate | 3 | 2021 | 1978 | 0.090 |
Why?
|
| Age Factors | 1 | 2016 | 1959 | 0.090 |
Why?
|
| Dietary Fats | 1 | 2011 | 137 | 0.080 |
Why?
|
| Faculty, Medical | 1 | 2013 | 207 | 0.080 |
Why?
|
| Decision Making | 1 | 2016 | 695 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2011 | 526 | 0.080 |
Why?
|
| Ginsenosides | 1 | 2011 | 124 | 0.080 |
Why?
|
| School Admission Criteria | 1 | 2010 | 31 | 0.080 |
Why?
|
| Plant Extracts | 1 | 2011 | 248 | 0.080 |
Why?
|
| Patient Discharge | 2 | 2024 | 363 | 0.080 |
Why?
|
| Sex Factors | 1 | 2012 | 1130 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 463 | 0.070 |
Why?
|
| Physicians | 1 | 2016 | 707 | 0.070 |
Why?
|
| ErbB Receptors | 1 | 2011 | 513 | 0.070 |
Why?
|
| Pain Measurement | 2 | 2020 | 378 | 0.070 |
Why?
|
| Regional Blood Flow | 2 | 2018 | 197 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 587 | 0.060 |
Why?
|
| Diet, Reducing | 1 | 2006 | 29 | 0.060 |
Why?
|
| North Carolina | 1 | 2006 | 56 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2015 | 4690 | 0.060 |
Why?
|
| Focus Groups | 1 | 2006 | 189 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2021 | 647 | 0.060 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2008 | 189 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2006 | 176 | 0.060 |
Why?
|
| Family Health | 1 | 2006 | 159 | 0.060 |
Why?
|
| Leadership | 1 | 2006 | 159 | 0.050 |
Why?
|
| Students, Medical | 1 | 2010 | 455 | 0.050 |
Why?
|
| Internal Medicine | 1 | 2008 | 371 | 0.050 |
Why?
|
| Young Adult | 1 | 2016 | 7034 | 0.050 |
Why?
|
| Adolescent | 1 | 2016 | 9878 | 0.050 |
Why?
|
| Exercise | 1 | 2006 | 355 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2006 | 816 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2020 | 3115 | 0.050 |
Why?
|
| Cathartics | 1 | 2022 | 27 | 0.050 |
Why?
|
| Subclavian Artery | 1 | 2021 | 42 | 0.040 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2021 | 56 | 0.040 |
Why?
|
| Heart Valves | 1 | 2021 | 26 | 0.040 |
Why?
|
| Caspase 3 | 1 | 2021 | 164 | 0.040 |
Why?
|
| Aftercare | 1 | 2021 | 90 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2024 | 364 | 0.040 |
Why?
|
| Medical Overuse | 1 | 2020 | 40 | 0.040 |
Why?
|
| Cause of Death | 1 | 2021 | 279 | 0.040 |
Why?
|
| Introns | 1 | 2021 | 304 | 0.040 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2021 | 242 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2021 | 405 | 0.040 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2020 | 66 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2020 | 311 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 2860 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 220 | 0.040 |
Why?
|
| Vascular Grafting | 1 | 2018 | 18 | 0.040 |
Why?
|
| Episode of Care | 1 | 2018 | 9 | 0.040 |
Why?
|
| Seasons | 1 | 2020 | 246 | 0.040 |
Why?
|
| Hepatitis B Vaccines | 1 | 2018 | 18 | 0.040 |
Why?
|
| Vascular Surgical Procedures | 1 | 2019 | 152 | 0.030 |
Why?
|
| Hepatitis B virus | 1 | 2018 | 48 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 890 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2022 | 502 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 281 | 0.030 |
Why?
|
| Time-to-Treatment | 1 | 2018 | 140 | 0.030 |
Why?
|
| Kidney | 1 | 2022 | 1135 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1962 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2018 | 323 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 2474 | 0.030 |
Why?
|
| Critical Pathways | 1 | 2016 | 36 | 0.030 |
Why?
|
| Stereotyping | 1 | 2016 | 17 | 0.030 |
Why?
|
| Health Communication | 1 | 2016 | 14 | 0.030 |
Why?
|
| Genome, Human | 1 | 2021 | 823 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 296 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2016 | 41 | 0.030 |
Why?
|
| Culture | 1 | 2016 | 54 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 1541 | 0.030 |
Why?
|
| Patient Selection | 1 | 2018 | 708 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 835 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 880 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2015 | 182 | 0.030 |
Why?
|
| Incidence | 1 | 2018 | 1723 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 1766 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 2059 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 365 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2013 | 376 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 491 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2013 | 362 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2016 | 636 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 205 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 311 | 0.020 |
Why?
|
| Heart Failure | 1 | 2020 | 1438 | 0.020 |
Why?
|
| Mutation | 1 | 2021 | 4374 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2011 | 686 | 0.020 |
Why?
|
| Data Collection | 1 | 2010 | 381 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 2777 | 0.020 |
Why?
|
| Colon | 1 | 2011 | 540 | 0.020 |
Why?
|
| Algorithms | 1 | 2016 | 2018 | 0.020 |
Why?
|
| Bacteria | 1 | 2011 | 516 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 1880 | 0.020 |
Why?
|
| HIV Infections | 1 | 2016 | 974 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 3642 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2011 | 824 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 2776 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 2534 | 0.010 |
Why?
|
| Mice | 1 | 2011 | 12525 | 0.010 |
Why?
|
| Animals | 1 | 2011 | 28901 | 0.010 |
Why?
|